HomeCompareISDR vs JNJ

ISDR vs JNJ: Dividend Comparison 2026

ISDR yields 20.73% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ISDR wins by $46.1K in total portfolio value
10 years
ISDR
ISDR
● Live price
20.73%
Share price
$9.65
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$76.3K
Annual income
$7,276.01
Full ISDR calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — ISDR vs JNJ

📍 ISDR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodISDRJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ISDR + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ISDR pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ISDR
Annual income on $10K today (after 15% tax)
$1,761.66/yr
After 10yr DRIP, annual income (after tax)
$6,184.61/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, ISDR beats the other by $2,198.62/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ISDR + JNJ for your $10,000?

ISDR: 50%JNJ: 50%
100% JNJ50/50100% ISDR
Portfolio after 10yr
$53.3K
Annual income
$5,982.71/yr
Blended yield
11.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ISDR
No analyst data
Altman Z
2.5
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ISDR buys
0
JNJ buys
0
No recent congressional trades found for ISDR or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricISDRJNJ
Forward yield20.73%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$76.3K$30.3K
Annual income after 10y$7,276.01$4,689.40
Total dividends collected$44.2K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ISDR vs JNJ ($10,000, DRIP)

YearISDR PortfolioISDR Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,773$2,072.54$10,592$272.30+$2.2KISDR
2$16,141$2,473.98$11,289$357.73+$4.9KISDR
3$20,192$2,921.83$12,123$472.89+$8.1KISDR
4$25,022$3,416.15$13,141$629.86+$11.9KISDR
5$30,730$3,956.28$14,408$846.81+$16.3KISDR
6$37,422$4,540.90$16,021$1,151.60+$21.4KISDR
7$45,209$5,168.01$18,122$1,588.22+$27.1KISDR
8$54,209$5,835.03$20,930$2,228.20+$33.3KISDR
9$64,542$6,538.87$24,792$3,191.91+$39.8KISDR
10$76,336$7,276.01$30,274$4,689.40+$46.1KISDR

ISDR vs JNJ: Complete Analysis 2026

ISDRStock

Issuer Direct Corporation provides shareholder communications and compliance platforms, technologies, and services in the United States and internationally. The company provides Platform id., a platform that manages the events of customers to distribute their messages to constituents, investors, markets, and regulatory systems; whistleblower hotline, which delivers secure notifications and basic incident workflow management processes that align with a company's corporate governance whistleblower policy; proxy module, a real-time voting platform for customers and their shareholders of record; and stock transfer module, a cloud-based platform, which provides access to real-time information about their shareholders, stock ledgers, and reports, as well as issues new shares. It also offers ACCESSWIRE, a news dissemination and media outreach service; and VisualWebcaster Platform, a cloud-based webcast, webinar, and virtual meeting platform that delivers live and on-demand streaming of events to audiences of various sizes, as well as allows customers to create, produce, and deliver events. In addition, the company provides investor relations content network, a series of data feeds, which include news feeds, stock feeds, fundamentals, regulatory filings, corporate governance, and other components; and professional conference and events software, a mobile app that offers organizers, issuers, and investors to register, request, and approve one-on-one meetings, as well as manage schedules, perform event promotion and sponsorship, print attendee badges, and manage lodging. It serves individuals, corporate issuers, public and private companies, law firms, brokerage firms, investment banks, and mutual funds; and professional firms, such as investor relations and public relations firms, as well as the accounting and legal communities. Issuer Direct Corporation was incorporated in 1988 and is headquartered in Raleigh, North Carolina.

Full ISDR Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this ISDR vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ISDR vs SCHDISDR vs JEPIISDR vs OISDR vs KOISDR vs MAINISDR vs ABBVISDR vs MRKISDR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.